Assessment of Minimal Residual Disease in Standard-Risk AML
N Engl J Med
.
2016 Aug 11;375(6):e9.
doi: 10.1056/NEJMc1603847.
Authors
Sarah Morin-Zorman
1
,
Aline Renneville
2
,
Lionel Adès
3
Affiliations
1
Hôpital Saint Louis, Paris, France sarah.morin@aphp.fr.
2
Centre Hospitalier Régional Universitaire de Lille, Lille, France.
3
Hôpital Saint Louis, Paris, France.
PMID:
27509126
DOI:
10.1056/NEJMc1603847
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Leukemia, Myeloid, Acute / genetics*
Mutation*
Nuclear Proteins / genetics*
Substances
Nuclear Proteins